These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 19016751)
1. Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease. Ye Q; Zheng MH; Cai Q; Feng B; Chen XH; Yu BQ; Gao YB; Ji J; Lu AG; Li JW; Wang ML; Liu BY Cancer Sci; 2008 Oct; 99(10):1924-32. PubMed ID: 19016751 [TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104 [TBL] [Abstract][Full Text] [Related]
3. Expression of gamma-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116. Ye Q; Feng B; Peng YF; Chen XH; Cai Q; Yu BQ; Li LH; Qiu MY; Liu BY; Zheng MH World J Gastroenterol; 2009 Oct; 15(40):5035-43. PubMed ID: 19859996 [TBL] [Abstract][Full Text] [Related]
4. [Demethylation of the gamma-synuclein gene CpG island in colorectal cancer and its clinical significance]. Ye Q; Feng B; Peng YF; Cai Q; Chen XH; Yu BQ; Ma JJ; Lu AG; Li JW; Wang ML; Liu BY; Zheng MH Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jun; 13(6):440-4. PubMed ID: 20577925 [TBL] [Abstract][Full Text] [Related]
5. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines. Yanagawa N; Tamura G; Honda T; Endoh M; Nishizuka S; Motoyama T Clin Cancer Res; 2004 Apr; 10(7):2447-51. PubMed ID: 15073123 [TBL] [Abstract][Full Text] [Related]
6. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223 [TBL] [Abstract][Full Text] [Related]
7. Methylation of Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151 [TBL] [Abstract][Full Text] [Related]
8. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer. Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827 [TBL] [Abstract][Full Text] [Related]
9. DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer. Kato K; Maesawa C; Itabashi T; Fujisawa K; Otsuka K; Kanno S; Tada H; Tatemichi Y; Kotani K; Oikawa H; Sugai T; Wakabayashi G; Masuda T Int J Oncol; 2009 Sep; 35(3):467-76. PubMed ID: 19639167 [TBL] [Abstract][Full Text] [Related]
10. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473 [TBL] [Abstract][Full Text] [Related]
11. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer. Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; JagodziĆski PP BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777 [TBL] [Abstract][Full Text] [Related]
12. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer. Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120 [TBL] [Abstract][Full Text] [Related]
13. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients. Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434 [TBL] [Abstract][Full Text] [Related]
14. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929 [TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage. Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105 [TBL] [Abstract][Full Text] [Related]
16. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy. Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879 [TBL] [Abstract][Full Text] [Related]
17. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312 [TBL] [Abstract][Full Text] [Related]
19. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line]. Fang XM; Sun LF; Peng JP; Dong Q; Zheng S Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2077-82. PubMed ID: 14703421 [TBL] [Abstract][Full Text] [Related]
20. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation. Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]